Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

Korshunovsky GOK reported for 9 months of 2023 by RAS

10/19/23 KOGK

Bank of America announced a quarterly dividend

10/19/23 BAC

Alcoa announced a quarterly dividend

10/19/23 AA

Alcoa reported for 9 months of 2023

10/19/23 AA

Nokia announced a quarterly dividend

10/19/23 NOK

TSMC reports for Q3 2023

10/19/23 TSM

Nokia reported for 9 months of 2023

10/19/23 NOK

Tesla has reported for Q3 of 2023

10/19/23 TSLA

Netflix reported for 9 months of 2023

10/19/23 NFLX

Magnet buys KazanExpress marketplace

10/19/23 MGNT